Can two targeted drugs boost chemo against a rare Bile-Duct cancer?
NCT ID NCT02711553
First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time
Summary
This phase 2 trial is testing whether adding either ramucirumab (a blood-vessel blocker) or merestinib (a cell-signal blocker) to standard chemotherapy (cisplatin + gemcitabine) can help people with advanced or metastatic biliary tract cancer live longer without their disease worsening. About 300 participants will be randomly assigned to one of three groups: chemo plus ramucirumab, chemo plus merestinib, or chemo plus placebo. The study aims to see if either targeted drug improves progression-free survival compared to chemo alone.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ramucirumab or merestinib added to cisplatin and gemcitabine chemotherapy
- What this could lead to
- If successful, this could provide a new first-line treatment option for people with advanced biliary tract cancer, potentially slowing tumor growth and extending survival.
- What could go wrong
- This is an early-phase trial, so the added drugs may not improve outcomes over standard chemo alone. Side effects from combining multiple agents could be significant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aarhus Universitetshospital, Aarhus Sygehus
Aarhus C, 8000, Denmark
-
Akdeniz University Medical Faculty
Antalya, 07059, Turkey (Türkiye)
-
Alexander Fleming
CABA, BS, 1426, Argentina
-
Arke Estudios Clinicos S.A. de C.V.
Mexico City, Mexico City, 06700, Mexico
-
Arkhangelsk Clinical Oncological Dispensary
Arkhangelsk, 163045, Russia
-
Asan Medical Center
Seoul, Korea, 05505, South Korea
-
Austin Health
Heidelberg, Victoria, 3084, Australia
-
Baskent University Dr. Turgut Noyan Research and Training Center
Adana, 1250, Turkey (Türkiye)
-
Blokhin Cancer Research Center
Moscow, 115478, Russia
-
CHRU de Montpellier-Hopital St Eloi
Montpellier, 34295, France
-
CHU de Besancon Hopital Jean Minjoz
Besançon, 25030, France
-
CHU de Bordeaux Hop St ANDRE
Bordeaux, Gironde, 33075, France
-
Calvary Mater Newcastle
Waratah, New South Wales, 2298, Australia
-
Centre Antoine-Lacassagne
Nice, 06189, France
-
Centre Leon Berard
Lyon, Auvergne-Rhône-Alpes, 69008, France
-
Centro Medico San Roque
San Miguel de Tucumán, Tucumán Province, 4000, Argentina
-
Centro Polivalente de Asistencia e Inv. Clinica CER-San Juan
San Juan, J5402DIL, Argentina
-
Centro de Alta Especialidad Reumatologia Inv del Potosi SC
San Luis Potosí City, 78213, Mexico
-
Chang Gung Memorial Hospital - Kaohsiung Branch
Kaohsiung City, 83301, Taiwan
-
Chang Gung Memorial Hospital - Linkou
Taoyuan City, 33305, Taiwan
-
China Medical University Hospital
Taichung, 40447, Taiwan
-
Clinica Viedma
Viedma, Río Negro Province, R8500ACE, Argentina
-
Cliniques universitaires Saint-Luc
Brussels, Brussels Capital, 1200, Belgium
-
Debreceni Egyetem Klinikai Kozpont Onkologiai Tanszek
Debrecen, Hajdú-Bihar, 4032, Hungary
-
Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet
Budapest, 1097, Hungary
-
Fakultni Nemocnice v Motole
Prague, 150 06, Czechia
-
Fakultni nemocnice Hradec Kralove
Hradec Králové, 500 05, Czechia
-
Florida Cancer Specialists
Nashville, Tennessee, 37203, United States
-
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111-2497, United States
-
Fundacion Ars Medica
San Salvador de Jujuy, Jujuy Province, Y4600APW, Argentina
-
Fundacion Favaloro
Ciudad de Buenos Aires, 1093, Argentina
-
Fundación CORI para la Investigación y Prevención del Cáncer
La Rioja, F5300COE, Argentina
-
Georgetown University Medical Center
Washington D.C., District of Columbia, 20007, United States
-
Gustave Roussy
Villejuif, 94805, France
-
HELIOS Klinikum Berlin-Buch
Berlin, 13125, Germany
-
Hacettepe University Faculty of Medicine
Ankara, 06100, Turkey (Türkiye)
-
Hammersmith Hospital
Acton, London, W12 0HS, United Kingdom
-
Hospital Clinico de San Carlos
Madrid, 28040, Spain
-
Hospital Clínico Universitario de Valencia
Barcelona, 46010, Spain
-
Hospital Duran I Reynals
L'Hospitalet de Llobregat, Barcelona, 08908, Spain
-
Hospital General Universitario Gregorio Marañon
Madrid, 28007, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital de Gastroenterologia Udaondo
Capital Federal, Buenos Aires, C1264AAA, Argentina
-
Hôpital C. HURIEZ
Lille, 59037, France
-
Istanbul Universitesi-Cerrahpasa Cerrahpasa Tip Fakultesi Yerleskesi
Istanbul, 34098, Turkey (Türkiye)
-
KH der Barmherzigen Brüder Wien
Vienna, 1020, Austria
-
Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Karolinska Universitetssjukhuset i Solna
Stockholm, 17176, Sweden
-
Landesklinikum Wr. Neustadt
Wiener Neustadt, Lower Austria, 2700, Austria
-
Masarykuv onkologicky ustav
Brno, Brno-město, 656 53, Czechia
-
Medizinische Hochschule Hanover
Hanover, Lower Saxony, 30625, Germany
-
National Cheng-Kung Uni. Hosp.
Tainan, 704, Taiwan
-
Odense Universitetshospital
Odense C, 5000, Denmark
-
Royal Adelaide Hospital
Adelaide, South Australia, 5000, Australia
-
Royal Marsden Hospital
Sutton, Surrey, SM2 5PT, United Kingdom
-
Russian Scientific Center of Radiology and Surgical Technologies
Saint Petersburg, Sankt-Peterburg, 197758, Russia
-
Saint-Petersburg City Clinical Oncology Dispensary
Saint Petersburg, 198255, Russia
-
Samsung Medical Center
Seoul, 06351, South Korea
-
Seoul National University Hospital
Seoul, Seoul, Korea, 03080, South Korea
-
Severance Hospital, Yonsei University Health System
Seoul, 03722, South Korea
-
Skåne universitetssjukhus
Malmö, 20502, Sweden
-
Taipei Veterans General Hospital
Taipei, 11217, Taiwan
-
Tennessee Oncology PLLC
Nashville, Tennessee, 37203, United States
-
The Christie NHS Foundation Trust
Manchester, Greater Manchester, M20 4BX, United Kingdom
-
The Clatterbridge Cancer Centre
Bebbington, Merseyside, CH63 4JY, United Kingdom
-
The University of Arizona Cancer Center
Tucson, Arizona, 85724, United States
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
-
Trakya University
Edirne, 22030, Turkey (Türkiye)
-
UCSF Medical Center at Mission Bay
San Francisco, California, 94158, United States
-
Universitaetsklinikum Hamburg-Eppendorf
Hamburg, 20246, Germany
-
Universitair Ziekenhuis Gent
Ghent, 9000, Belgium
-
Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg
Leuven, 3000, Belgium
-
University College Hospital - London
London, Greater London, NW1 2BU, United Kingdom
-
University of Florida School of Medicine
Gainesville, Florida, 32608, United States
-
Universitätsklinikum Erlangen
Erlangen, Bavaria, 91054, Germany
-
Universitätsklinikum Salzburg
Salzburg, 5020, Austria
-
Universitätsklinikum Tübingen
Tübingen, Baden-Wurttemberg, 72076, Germany
-
Universitätsklinikum Ulm
Ulm, Baden-Wurttemberg, 89081, Germany
-
Washington University Medical School
City of Saint Peters, Missouri, 63376, United States
-
Washington University Medical School
Creve Coeur, Missouri, 63141, United States
-
Washington University Medical School
St Louis, Missouri, 63110, United States
-
Washington University Medical School
St Louis, Missouri, 63129, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can freezing tumors boost immunotherapy in hard-to-treat bile duct cancers?
- Can a new nucleotide analogue boost cancer treatment?
- Zapping resistant tumors with precision radiation may extend the life of current cancer therapy
- Can a cancer vaccine train the body to fight advanced tumors?
- Triple attack on bile duct cancer: chemo, targeted drug, and immunotherapy aim to make the inoperable operable
- Liver tumors targeted directly: old pump, new drug